Highlights Dr. Lal PathLabs Limited Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Market Closed - Bombay S.E. Other stock markets 11:00:58 05/07/2024 BST			5-day change	1st Jan Change
2,884 ^INR	-0.83%		+3.76%	+12.03%

06-29	Dr. Lal PathLabs Limited Declares Final Dividend for the Financial Year Ended March 31, 2024	CI
05-14	Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Dr. Lal PathLabs Limited Declares Final Dividend for the Financial Year Ended March 31, 2024	06-29	CI
Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	05-13	MT
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	05-10	RE
Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	05-10	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-10	CI
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	02-02	MT
Dr. Lal PathLabs Seeks M&A	02-01	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	02-01	RE
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	02-01	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-01	CI
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	01-25	MT
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	11-03	MT
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	12/09/23	CI
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	31/07/23	MT
Dr. Lal PathLabs Seeks Inorganic Opportunity	27/07/23	CI
Dr. Lal Pathlabs Limited Proposes Interim Dividend for the Financial Year 2023-24	27/07/23	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27/07/23	CI
Dr. Lal PathLabs Limited acquired additional 10% stake in Aprl Pathlabs Private Limited.	26/07/23	CI
Dr. Lal PathLabs' Consolidated Net Profit Declines in Fiscal Q4; Shares Up 3%	12/05/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Dr. Lal PathLabs Limited Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Highlights

Filters